In a study looking at the drug tirzepatide, people lost an average of 15%-20% of their body weight
CD44 (Abcam, ab189524, clone EPR18668, lot 1014086-32, WB, 1:30,000, Hu, KO and KD validated in-house)
With the GLP-1 Supply Tracker, anyone can enter the drug, dose, and pharmacy where they found stock of a GLP-1 drug or enter the same information about a pharmacys shortage
These findings suggest that such drug formulations hold great promise for clinical application in TNBC, as summarized in Table 1 (44)
Write the peptide name, concentration (e.g., "Retatrutide 10 mg/mL"), and today's date on the vial